Year: 2018

Prexton News

Prexton Acquired by Lundbeck for up to €905m

Oss, The Netherlands & Dublin, Ireland, 16 March 2018 – H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under the terms of the agreement, Lundbeck will pay EUR 100 million upfront plus EUR 805 million in development …

Prexton Acquired by Lundbeck for up to €905m Read More »

Pq Bypass

Doctors Perform ‘Bypass’ Without Surgery

Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week.  Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story was carried on Little Rock’s news source, ArkansasMatters. You can watch a video of the story here and read the full ArkansasMatters story below. Doctors …

Doctors Perform ‘Bypass’ Without Surgery Read More »

Pq Bypass

PQ Bypass Announces First Patient Treated in DETOUR II Trial

PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries.  Pivotal Trial Now Underway in the United States for First-of-its-Kind Procedure in Patients with Severe Peripheral Artery Disease (PAD) SUNNYVALE, Calif. – February 22, 2018 – PQ Bypass, a clinical-stage medical technology company that has developed …

PQ Bypass Announces First Patient Treated in DETOUR II Trial Read More »

Biomimics 3d

Veryan Announces Submission of its PMA Application to the FDA

1 February 2018: Seroba’s investee company, Veryan Medical, has announced that the Company has submitted a Premarket Approval (PMA) application for the BioMimics 3D Vascular Stent System to the U.S. Food & Drug Administration. Pivotal to the content of the PMA application are the 12-month interim safety and effectiveness results from the Company’s MIMICS-2 clinical study …

Veryan Announces Submission of its PMA Application to the FDA Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top